GLP-1 Muscle Loss — The Hidden Risk cover art

GLP-1 Muscle Loss — The Hidden Risk

GLP-1 Muscle Loss — The Hidden Risk

Written by: Inception Point Ai
Listen for free

About this listen

 GLP-1 drugs like Ozempic trigger dramatic weight loss, but up to 40% may be muscle, not fat. Dr. Ben Synth unpacks the hidden metabolic cost, science-backed preservation strategies, and breakthrough therapies that could revolutionize how we lose weight without losing strength.

For more content like this, visit QuietPlease.aiCopyright 2025 Inception Point Ai Exercise & Fitness Fitness, Diet & Nutrition Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • GLP-1 Muscle Loss — The Hidden Risk - The Race to Build a Better Drug

    GLP-1 Muscle Loss — The Hidden Risk - The Race to Build a Better Drug
    Apr 7 2026
    Host Ben Synth explores groundbreaking research on GLP-1 weight loss drugs and muscle preservation. He examines the BELIEVE study combining semaglutide with bimagrumab, which achieved 92.8% fat loss versus lean tissue loss, and discusses revolutionary continuous biosensor technology tracking muscle breakdown in real-time for patients on medications like Ozempic and Mounjaro.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Show More Show Less
    25 mins
No reviews yet